K Pharma,Inc. (TYO:4896)

Revenue by Product

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Research, Development, Manufacturing, and Sales of Pharmaceuticals	1.00B

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Japan	1.00B